Tony Michael Argenbright

Array ( [id] => 5937362 [patent_doc_number] => 20110212900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'METHOD FOR PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF PAIN ASSOCIATED WITH HEMATOPOIETIC CELL TRANSPLANTATION' [patent_app_type] => utility [patent_app_number] => 12/869477 [patent_app_country] => US [patent_app_date] => 2010-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 17389 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212900.pdf [firstpage_image] =>[orig_patent_app_number] => 12869477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6403825 [patent_doc_number] => 20100305308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'Lactoferrin' [patent_app_type] => utility [patent_app_number] => 12/853149 [patent_app_country] => US [patent_app_date] => 2010-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4749 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305308.pdf [firstpage_image] =>[orig_patent_app_number] => 12853149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071209 [patent_doc_number] => 20110046060 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'Coagulation factor IX compositions and methods of making and using same' [patent_app_type] => utility [patent_app_number] => 12/806004 [patent_app_country] => US [patent_app_date] => 2010-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 98716 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046060.pdf [firstpage_image] =>[orig_patent_app_number] => 12806004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148756 [patent_doc_number] => 20110020351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'NOVEL POLYPEPTIDE ESDN, POLYNUCLEOTIDES ENCODING THE POLYPEPTIDE, AND UTILITY OF THE POLYPEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/819584 [patent_app_country] => US [patent_app_date] => 2010-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8370 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020351.pdf [firstpage_image] =>[orig_patent_app_number] => 12819584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128539 [patent_doc_number] => 20110087004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGNOSTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/818955 [patent_app_country] => US [patent_app_date] => 2010-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 29179 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20110087004.pdf [firstpage_image] =>[orig_patent_app_number] => 12818955 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846435 [patent_doc_number] => 08455617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Melanocortin receptor-specific peptides' [patent_app_type] => utility [patent_app_number] => 12/795469 [patent_app_country] => US [patent_app_date] => 2010-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25458 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12795469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6387716 [patent_doc_number] => 20100317596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-16 [patent_title] => 'SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE' [patent_app_type] => utility [patent_app_number] => 12/794132 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19892 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20100317596.pdf [firstpage_image] =>[orig_patent_app_number] => 12794132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6343001 [patent_doc_number] => 20100330025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'Surface Independent, Surface-Modifying, Multifunctional Coatings and Applications Thereof' [patent_app_type] => utility [patent_app_number] => 12/793653 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 58 [patent_figures_cnt] => 58 [patent_no_of_words] => 22085 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0330/20100330025.pdf [firstpage_image] =>[orig_patent_app_number] => 12793653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196628 [patent_doc_number] => 20110028386 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Antimicrobial Peptides' [patent_app_type] => utility [patent_app_number] => 12/793666 [patent_app_country] => US [patent_app_date] => 2010-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 34147 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028386.pdf [firstpage_image] =>[orig_patent_app_number] => 12793666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6401173 [patent_doc_number] => 20100305050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'PROTEIN PRODUCT WITH MODIFIED ANTIGENICITY' [patent_app_type] => utility [patent_app_number] => 12/792133 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 3495 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305050.pdf [firstpage_image] =>[orig_patent_app_number] => 12792133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4596023 [patent_doc_number] => 07981858 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2011-07-19 [patent_title] => 'Methods of using zinc containing compounds to improve ocular health' [patent_app_type] => utility [patent_app_number] => 12/782057 [patent_app_country] => US [patent_app_date] => 2010-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2663 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981858.pdf [firstpage_image] =>[orig_patent_app_number] => 12782057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6602749 [patent_doc_number] => 20100292436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'METHOD FOR PRODUCING BIVALIRUDIN' [patent_app_type] => utility [patent_app_number] => 12/781037 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4114 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292436.pdf [firstpage_image] =>[orig_patent_app_number] => 12781037 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7712713 [patent_doc_number] => 08093354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-10 [patent_title] => 'Process for preparing glycopeptide phosphonate derivatives' [patent_app_type] => utility [patent_app_number] => 12/759076 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6173 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/093/08093354.pdf [firstpage_image] =>[orig_patent_app_number] => 12759076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7527603 [patent_doc_number] => 08044195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-25 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 12/759073 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17146 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/044/08044195.pdf [firstpage_image] =>[orig_patent_app_number] => 12759073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6629710 [patent_doc_number] => 20100311669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'COMPOUNDS THAT BIND TO P185 AND METHODS OF USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/758435 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20995 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311669.pdf [firstpage_image] =>[orig_patent_app_number] => 12758435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6328667 [patent_doc_number] => 20100197798 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS' [patent_app_type] => utility [patent_app_number] => 12/756773 [patent_app_country] => US [patent_app_date] => 2010-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 30375 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197798.pdf [firstpage_image] =>[orig_patent_app_number] => 12756773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6326867 [patent_doc_number] => 20100197594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-05 [patent_title] => 'METHODS FOR USING SOY PEPTIDES TO INHIBIT H3 ACETYLATION, REDUCE EXPRESSION OF HMG-COA REDUCTASE AND INCREASE LDL RECEPTOR AND SP1 EXPRESSION IN A MAMMAL' [patent_app_type] => utility [patent_app_number] => 12/756126 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14993 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20100197594.pdf [firstpage_image] =>[orig_patent_app_number] => 12756126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6613744 [patent_doc_number] => 20100310474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'PROTEIN CAGES FOR THE DELIVERY OF MEDICAL IMAGING AND THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/752905 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22411 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0310/20100310474.pdf [firstpage_image] =>[orig_patent_app_number] => 12752905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9869412 [patent_doc_number] => 08957184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-17 [patent_title] => 'Pro-apoptotic peptides' [patent_app_type] => utility [patent_app_number] => 13/262067 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6048 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13262067 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6231512 [patent_doc_number] => 20100184690 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications' [patent_app_type] => utility [patent_app_number] => 12/748869 [patent_app_country] => US [patent_app_date] => 2010-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6469 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20100184690.pdf [firstpage_image] =>[orig_patent_app_number] => 12748869 [rel_patent_id] =>[rel_patent_doc_number] =>)